Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
Stock Snapshot
With a market cap of 358.43B, Merck(MRK) trades at $145.40. The stock has a price-to-earnings ratio of 117.69 and currently yields dividends of 2.31%.
On 2026-10-23, Merck(MRK) stock traded between a low of $143.41 and a high of $146.50. Shares are currently priced at $145.40, which is +1.4% above the low and -0.8% below the high.
Merck(MRK) shares are trading with a volume of 8.38M, against a daily average of 10.9M.
During the past year, Merck(MRK) stock moved between $82.01 at its lowest and $156.92 at its peak.
During the past year, Merck(MRK) stock moved between $82.01 at its lowest and $156.92 at its peak.
MRK News
Investing AbbVie’s Dividend Survived Humira’s Patent Cliff. Will Merck and Amgen’s? When a drugmaker's top product loses patent protection, the dividend usually...
Moderna and Merck proved their custom cancer vaccine cut the risk of melanoma returning for longer than the cancer drug Keytruda, but it may take several years...
Moderna (MRNA Quick QuoteMRNA - Free Report) , along with partner Merck (MRK Quick QuoteMRK - Free Report) , reported detailed positive results from t...
Analyst ratings
68%
of 31 ratingsMore MRK News
Investing Moderna Sinks 4% After 18% Plunge as Melanoma Vaccine Selloff Extends; Merck and Pfizer Slip Full late-stage results for the personalized melanoma vac...
Merck (MRK) is back in the spotlight after detailed Phase 3 INTerpath-001 data showed its personalized melanoma vaccine intismeran, combined with Keytruda, cut...
Moderna shares dropped as much as 25% on Thursday following the leak of partial data on its closely watched cancer vaccine developed with Merck . Shares of bot...
Merck (MRK) and Moderna (MRNA) announced detailed positive recurrence-free survival and distant metastasis-free survival results from the Phase 3 INTerpath-001...
Moderna Inc. (NASDAQ:MRNA) stock plunged more than 25% Thursday after the alleged leak of an ESMO 2026 conference abstract raised concerns about the effectivene...
Investing Moderna Tumbles 25% After Apparent Early Leak of Melanoma Vaccine Data; BioNTech Dips, Pfizer Edges Higher A melanoma vaccine report appeared online,...
The stock of pharmaceutical company Moderna (MRNA) is down 25% in afternoon trading on Oct. 22 amid reports that data concerning its new cancer drug has been le...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.